Compare OLMA & DFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OLMA | DFIN |
|---|---|---|
| Founded | 2006 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2020 | 2017 |
| Metric | OLMA | DFIN |
|---|---|---|
| Price | $15.39 | $46.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 2 |
| Target Price | $44.89 | ★ $61.50 |
| AVG Volume (30 Days) | ★ 1.7M | 229.3K |
| Earning Date | 03-16-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 15.00 | N/A |
| EPS | N/A | ★ 1.15 |
| Revenue | N/A | ★ $963,000,000.00 |
| Revenue This Year | N/A | $4.98 |
| Revenue Next Year | $347.47 | $3.87 |
| P/E Ratio | ★ N/A | $41.01 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.86 | $37.07 |
| 52 Week High | $36.26 | $66.25 |
| Indicator | OLMA | DFIN |
|---|---|---|
| Relative Strength Index (RSI) | 39.54 | 44.66 |
| Support Level | $13.11 | $44.46 |
| Resistance Level | $27.38 | $50.46 |
| Average True Range (ATR) | 0.99 | 1.63 |
| MACD | 0.30 | -0.10 |
| Stochastic Oscillator | 57.80 | 22.57 |
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
Donnelley Financial Solutions Inc is a risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( USA), Europe, Asia, Canada, and others, of which the USA accounts for the vast majority of its total revenue.